Exchange: NASDAQ·Updated 05:43 PM EST
PLUR logo

PLUR Pluri Inc

$1.07
$0.0454
(3.81%)
Today
Closed $1.24
$0.1653
(13.38%)
After Hours
Mkt Cap$15.58M
Vol4,750.00

About PLUR

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
36

Bearish Sentiment

How do you feel about PLUR?

focafoca99
$PLUR agreed to a partnership with ZEO ScientifiX, securing an exclusive US license and a 41% equity stake in the biotech firm.
1
PLURI_JUGGERNAUT_
$PLUR Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments English-language call at 8:30 a.m. Eastern Time and Hebrew-language call at 11:00 a.m. Israel Time on Thursday, October 29, 2026.
1
openmarketalerts
$PLUR — Director Manieu Alexandre Weinstein bought $1.3M of stock on Oct 23. • 833,334 shares at $1.50. • Bought near the 52-week low. • Stake up 66%.
1
Bumbleclod
$PLUR there's nothing here short this pig into the ground....... Fluff news for the last 10 years go back and see for yourselves.....

Advertisement|Remove ads.